Download - Bayer HealthCare

More documents

Recommendations

Info

More and more doctors and patients rely on innovative drugs from Bayer HealthCare’s Pharmaceuticals Division. 12 Pharmaceuticals net sales 2012: approx. € 10.8 billion Headquarters: Berlin, Germany
Bayer HealthCare’s success story in the pharmaceuticals business began 125 years ago. The first product marketed by the “Pharmaceutical Department” of Bayer was the antipyretic Phenacetin in 1888. Bayer also quickly developed a reputation espe- cially in the treatment of infectious diseases. Bayer researcher Gerhard Domagk, who discovered the antibacterial effect of sulfonamides, was awarded the nobel Prize in Medicine in 1939. Bayer HealthCare Pharmaceuticals today holds a worldwide leading position in its main therapeutic areas. The focus on specialty pharmaceuticals and the opportunities for growth in the field of general medicine offer an outstanding basis for sustainable expansion. The division combines its strengths in two business units: General Medicine and Specialty Medicine. The General Medicine Business Unit develops and markets products that are prescribed by both general practitioners and medical specialists. Our extensive range of products in this segment – for the control of high blood pressure, prevention of myocardial infarction and stroke, and for diabetes management – offer doctors and patients options in both the treatment and prevention of acute disease conditions. The company also markets effective drug products to treat bacterial infections, such as respiratory tract and urinary tract infections. In the field of Men’s Health, the division offers a wide range of therapeutic options, including treatments for erectile dysfunction and testosterone deficiency. In 2008, Bayer HealthCare launched a novel oral Factor Xa inhibitor for the prevention of life-threatening blood clots that is taken once daily in most indications. This product is now registered in more than 120 countries for the prevention of thrombosis after elective hip or knee replacement surgery; further indications have since also been added. In the field of Women’s Healthcare, the company is currently concentrating on three areas: contraception, menopause management and the development of gynecological treatments. Bayer is the world leader in the field of female hormonal contraception, in particular in the area of oral contraception. The “pill” has been helping women plan their families for more than 50 years. Bayer HealthCare offers a wide range of different contraceptives to meet individual needs, including a low-dosage contraceptive which is the first product from a new class of oral contraceptives whose estrogen component has the same action as estradiol, an estrogen that is produced by the female body. For women who do not wish to take a daily contraceptive pill, the company offers long-term intrauterine contraceptive systems with a duration of action of up to five years. The range also includes products to relieve the symptoms associated with menopause. In the gynecological therapy segment, Bayer HealthCare is working to develop new therapeutic options for conditions with a high level of unmet medical need such as uterine fibroids (myomas) and endometriosis, a condition in which endometrial cells grow outside PHArMACEuTiCAlS DIVISIOn 13
Page 1 and 2: Bayer HealthCare A Company Overview
Page 3 and 4: innovations in health care Bayer He
Page 5 and 6: or farm animals for food production
Page 7 and 8: The goals of the Animal Health Divi
Page 9 and 10: A growing number of individuals wor
Page 11: Bayer HealthCare’s Medical Care D
Page 15 and 16: Continued from page 13 of the uteru
Page 17 and 18: €1,962 million of the Bayer Group
Page 19 and 20: expertise. The current R&D focus in
Page 21 and 22: Bayer HealthCare manufactures produ
Page 23 and 24: As an innovation- and growth-orient
Page 25 and 26: in the 21st century, the world will
Page 27 and 28: Bayer HealthCare names - Figures -
Page 29 and 30: Germany United States China Japan M

Download - Bayer HealthCare

Create successful ePaper yourself

Delete template?

Save as template?